Bacillus cereus bacteremia with central nervous system involvement: A neuropathological study. by Brouland, J.P. et al.
Clinical Neuropathology, Vol. 37 – No. 1/2018 (22-27) 
©2018 Dustri-Verlag Dr. K. Feistle 
ISSN 0722-5091 
DOI 10.5414/NP301041
e-pub: October 16, 2017
Received
May 11, 2017;
accepted in revised form
July 19, 2017
Correspondence to
Jean Philippe Brouland, 
MD, PhD 
Institute of Pathology, 
CHUV – Lausanne 
University Hospital,  
Rue du Bugnon 25, 
1011 Lausanne, 
Switzerland 
Jean-philippe.
brouland@chuv.ch
Key words
Bacillus cereus 
– bacteremia – septice-
mia – central nervous 
system – neuropathol-
ogy
Bacillus cereus bacteremia with central 
nervous system involvement: 
A neuropathological study
Jean Philippe Brouland1, Nathalie Sala1, Selin Tusgul2, Caterina Rebecchini1, and 
Enikö Kovari1,3
1Institute of Pathology, 2Service of Internal Medicine, Department of Medicine, 
University Hospital-CHUV Faculty of Medicine, Lausanne, and  
3Unit of Biomarkers, Department of Mental Health and Psychiatry, Geneva 
University and Faculty of Medicine, Geneva, Switzerland
Abstract. Bacillus cereus is a widely-
distributed, gram-positive or variable, rod-
shaped bacterium frequently considered a 
contaminant in clinical specimens. It is rec-
ognized as a potential pathogen inducing 
self-limiting emetic or diarrheal food poison-
ing or localized infection in immunocompe-
tent patients. True B. cereus bacteremia is 
uncommon and mainly observed in fragile 
patients, notably in immunocompromised 
individuals. We report clinical, radiological, 
and pathological findings of a 64-year-old 
patient with a history of acute myeloid leu-
kemia who initially presented a fever while 
neutropenic after the induction of a second 
cycle of chemotherapy. He developed B. ce-
reus bacteremia with invasive infection and 
a fatal outcome. The clinical and radiologi-
cal data of this case are compared to a pre-
viously-published series of 21 patients from 
our institution with B. cereus bacteremia. 
This study highlights the clinical challenge 
to diagnose B. cereus and the importance of 
the delay between the detection of B. cereus 
and the initiation of an effective targeted an-
tibiotic therapy. This case presented an ag-
gressive evolution with multiple necrotic and 
hemorrhagic foci in the brain. Upon histo-
logical examination, B. cereus virulence was 
notably reflected by the dissection of blood 
vessel walls by the bacilli and luminal occlu-
sion, a pattern that has not been yet reported.
Introduction
Bacillus cereus is a ubiquitous and het-
erogeneous group of gram-positive or gram-
variable, aerobic facultative, spore-forming, 
rod shaped bacterium [1], frequently con-
sidered a contaminant in clinical specimens. 
However, it is recognized as a potential 
pathogen inducing self-limiting emetic or di-
arrheal food poisoning [2] or localized infec-
tion in immunocompetent patients [1]. B. ce-
reus bacteremia with infection of the central 
nervous system (CNS) is uncommon and has 
mostly been reported in patients with hema-
tological malignancies [3, 4, 5]. This report 
describes the clinical, radiological, and path-
ological features of a fatal disseminated B. 
cereus infection with CNS involvement. The 
clinical and radiological data are compared 
to those of a published series of 21 patients 
from our institution with B. cereus bactere-
mia [4].
Case report
A 64-year-old man with acute myeloid 
leukemia (AML) with myelodysplasia-related 
changes (multilineage dysplasia) and NPM1 
and WT1 mutations was referred to our hos-
pital for the second cycle of chemotherapy 
(lenalidomide 15 mg/days (d) 1 – 21, cytara-
bine 200 mg/m2 d1 – d7, idarubicin 12 mg/
m2 d1 – d3). The first cycle of chemotherapy, 
1 month earlier, was followed by an episode 
of agranulocytosis with fever, left frontal 
headache, and left nasal obstruction, which 
was empirically treated by cefepime for 
5 days. On day 5, two fever spikes (38 °C) 
were recorded, without agranulocytosis, and 
on day 6 a third one (38.7  °C), with agranu-
locytosis. Four pairs of central catheter and 
peripheral blood cultures and urine cultures 
were performed with negative results. Em-
pirical treatment by cefepime was initiated 
on day 6. The next day, metronidazol was 
added due to an episode of diarrhea without 
abdominal pain. Results of fecal cultures 
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were negative. From day 7 to day 12, cor-
ticosteroid therapy was started due to the 
apparition of a cutaneous rash and of a face 
and finger edema considered a side effect of 
cytarabine treatment. In view of the clinical 
improvement and the negative blood and 
urine cultures, it was decided to stop antibi-
otic therapy after 5 days.
Figure 1. Brain imaging and neuropathological findings. A: Cerebral CT scan: acute lenticulostriated 
bleeding (blue arrow). B: Gross examination, coronal section: focus of hemorrhage in the lenticulostriated 
area (blue arrow); subarachnoid small foci of hemorrhage (green arrow); multiple disseminated round in-
fracentimetric lesions (red arrow). C – I: Brain, histological examination: subcortical focus of necrosis with 
numerous bacilli visible on H & E (C, × 20; D × 200), gram-positive (E, × 400), positive with Grocott’s silver 
impregnation (F, × 600), and PAS-positive (G, × 400). H, I: Brain, thrombosed blood vessel with laminated 
wall dissected and infiltrated by B. cereus (H, H & E × 100; I, Grocott’s stain, × 400). J – L: Liver, Large 
areas of geographic necrosis (J, gross examination; K, H & E × 20), B. cereus infiltrating liver parenchyma 
(L, H & E, × 600).
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On day 12, early in the morning, the pa-
tient suddenly presented a shock of unknown 
origin and acute hepatic failure. Peripheral 
and central venous catheter blood samples 
were drawn, and an emergency empirical 
treatment with cefepime was initiated. Me-
ropenem, vancomycin, and amikacin re-
placed it within hours when 3 out of 4 blood 
cultures returned positive for B. cereus. Met-
ronidazol was added due to another episode 
of diarrhea. Thoracoabdominal CT scan re-
vealed a typical bilateral bronchopneumo-
nia and a heterogeneous aspect of the liver 
parenchyma with multiple nodular hypoden-
sities. Cerebral CT scan showed an acute 
lenticulostriatal bleed (Figure 1A), small 
bilateral frontoparietal cerebral lesions, and 
a cortico-subcortical occipital hypodensity. 
Despite intensive care and support, the pa-
tient died the next day.
Neuropathological and general 
autopsy findings
At postmortem examination, the brain 
weighted 1,670 g. Gross examination re-
vealed an edematous appearance with flat-
tening of the gyri without cerebral hernia-
tion. On coronal sections, there were small 
bilateral frontal and parietal subarachnoid 
hemorrhagic foci; a 1.2 cm hemorrhagic fo-
cus in the lenticulostriatal area with discrete 
compression of the right ventricle; and a left 
occipital necrotico-hemorrhagic focus (Fig-
ure 1B). In addition, multiple round lesions 
of 0.3 – 0.5 cm in diameter were dissemi-
nated in the left internal capsule, putamen, 
and subcortical parietal areas and in the right 
parietal para-medial area.
At histological examination (Figure 1C, 
D, E, F, G), the multiple disseminated intra-
parenchymatous and subcortical lesions con-
sisted of foci of liquefaction necrosis contain-
ing numerous gram-variable bacilli that were 
also PAS- and Grocott-positive, consistent 
with B. cereus. The bacilli invaded and dis-
sected vascular walls as an infectious vascu-
litis but without inflammatory infiltrate and, 
notably, a lack of neutrophils (Figure 1I). In 
the immediate vicinity, some blood vessel 
lumens were occluded by thrombus (Figure 
1H). Demyelination features were observed 
surrounding the necrotic foci whereas further 
from the lesions, brain parenchyma and, no-
tably, white matter was unremarkable.
The liver (Figure 1J, K, L) macroscopi-
cally showed large areas of necrosis without 
specific zonation and involving more than 
50% of parenchyma. Histologically, the ne-
crosis was of the same type as in the brain 
parenchyma without inflammatory infiltrate 
and containing numerous gram-variable ba-
cilli. There was no significant fibrosis.
The lungs exhibited fibrosis of the alveo-
lar septa as well as edematous and hemor-
rhagic alveolitis. Extensive aseptic acute re-
nal tubular necrosis and pancreatic necrosis 
was observed, likely due to terminal multior-
gan failure (MOF). The stomach, small intes-
tine, colon, and rectum were unremarkable, 
notably without any ulceration or necrotic 
focus. Except in the vicinity or in necrotic 
and hemorrhagic areas of the brain and the 
liver, there was occlusion of the blood vessel 
lumen by thrombus.
Microbiologic methods
Identification of B. cereus from blood 
culture was based on Gram staining, colony 
morphology, and hemolysis on blood agar, 
positive lecithinase on egg yolk agar or 
matrix-assisted laser desorption/ionization 
(MALDI-TOF). Antimicrobial susceptibility 
testing was performed using disk diffusion 
and E-test as previously described [4].
Discussion
We report a fatal case of B. cereus septi-
cemia in a patient undergoing the second cy-
cle of chemotherapy for AML. The clinical 
course ended with a fatal septic shock 6 days 
after chemotherapy-induced neutropenia, 
with hepatic failure, multiple abscesses in 
the liver parenchyma, and brain parenchyma 
in association with hemorrhagic foci.
Compiled with previously-reported clini-
cal and radiological data on patients with 
positive blood culture for B. cereus collected 
in our institution from 1999 to 2013 and pub-
lished elsewhere [4], this case is the fifth he-
matological patient with involvement of the 
CNS by B. cereus (Table 1). Four out of the 
5 patients presented an AML, confirming the 
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high risk of B. cereus CNS location in this 
type of disease, as previously reported [3]. 
Amongst the 22 patients with positive blood 
cultures for B. cereus, 11 had a hematologi-
cal malignancy, 5 presented neurological 
symptoms, 3 exhibited brain abscesses or ne-
crotic foci, and 1 meningoencephalitis.
Food source at the origin of B. cereus 
spread in the bloodstream has been reported 
by Vodopivec et al. [5] and resulted in chang-
ing the dietary management of patients with 
hematological diseases. Possible mechanisms 
include the entrance of the bacteria through 
mucosal breaches, induced by chemotherapy 
agents such as cytarabine, and subsequent 
hematogenous dissemination to the CNS. 
This differs from the cases reported by Tusgul 
et al. [4] where spread from an internal de-
vice, such as an intravascular catheter, was 
the only factor of risk for CNS involvement. 
Although our patient effectively presented 
with diarrhea, negative fecal cultures, and 
absence of gastrointestinal ulceration at post-
mortem examination do not argue in favor of 
a digestive bacterial translocation.
Chemotherapy-induced pancytopenia with 
severe neutropenia was observed in the 5 pa-
tients with AML or MDS and seems to be a 
Table 1. Clinical and imaging findings of the currently-reported patient and of the 4 patients in Tusgul et al. series [4] with hemato-
logical disease and involvement of the central nervous system.
Patient number Reported patient 3 6 19 20
Sex M F M M M
Age 64 57 46 63 41
Diagnosis AML AML MDS AML AML
Therapy Second cycle of 
chemotherapy, 
corticosteroid 
therapy
Consolidation 
chemotherapy
Third cycle of 
chemotherapy, 
corticosteroid 
therapy
Second cycle of 
chemotherapy
Neutropenia 
duration before 
bacteremia (days)
5 7 17 14 15
Intravascular 
catheter at the time 
of bacteremia
Yes Yes Yes Yes Yes
Neurological 
symptoms
Sudden central 
nervous system 
depression, coma
Psychomotor 
agitation, disorder  
in vigilance, 
left brachio-facial 
hemiparesis, signs 
of dysautonomia 
with hypertensive 
peaks and 
myoclonia
Headache Bi-temporal 
headache, blurred 
vision, motor 
dysfunction of left big 
toe and left thigh, 
dysdiadochokinesia; 
worsening of left 
upper and lower limb 
hemiparesis
Abdominal pain, 
headache, and 
disorder of 
vigilance
Radiological signs Acute lenticulostria-
tal bleeding, bilateral 
fronto-parietal 
lesions and occipital 
cortico-subcortical 
hypo density
Diffuse meningeal 
thickening, lack of 
focal lesion
6-mm nodular 
hyperdense lesion 
in the left basal 
ganglia and edema 
around the lesion
Leptomeningeal and 
bilateral temporo-
parietal infiltration; 
then, supra- and 
infratentorial multiple 
infracentimetric foci 
of hemorrhage and a 
larger one in the 
right motor cortex
Subdural  
hematoma
BC therapy Targeted, 1 day Targeted, 15 days Empirical by 
vancomycin, 
6 weeks
Targeted, 15 weeks 
and prophylactic, 
18 weeks
Targeted, 20 days
Evolution Death Regression of the 
clinical symptoms
Regression of 
clinical symptoms; 
hypodense scar 
lesion in the left 
basal ganglia
Regression of 
clinical symptoms 
and radiological 
lesions
Death due to the 
fast development 
of hematological 
disease
AML = acute myeloid leukemia; MDS = myelodysplastic syndrome; BC = Bacillus cereus.
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major risk factor for unfavorable outcomes 
for B. cereus infection [3, 5].
The pathogenicity of B. cereus is related 
to its ability to secrete various toxins, notably 
hemolytic and nonhemolytic enterotoxins as 
well as emetic (cereulide) toxins involved in 
food poisoning [1, 6]. Others, such as hemo-
lysin II, phosphatidyl inositol phospholipase 
C, sphingomyelinase, pore-forming cytotox-
ins, have been reported as major determi-
nants of tissue necrosis [7, 8]. In the present 
case, neutropenia is reflected by the absence 
of neutrophil inflammatory response in and 
around the necrotic foci. This indicates that 
brain and liver tissue lesions are mainly due 
to intrinsic B. cereus aggressiveness unlike 
other acute bacterial infections where tissue 
lesions, such as necrosis, mostly result from 
enzymes released by inflammatory cells, 
notably neutrophils. Regarding secretion of 
sphingomyelinase and phospholipase, we 
looked for demyelination features, which 
were only observed surrounding necrotic 
foci, favoring a local action of these toxins.
Foci of cerebral, subpial, and subarach-
noid hemorrhage may result from various 
causes including distant action of B. cereus 
hemolysins, deficiency in coagulation factors 
due to dramatic hepatic failure, or thrombo-
cytopenia.
In our patient, vasculitic lesions induced 
by B. cereus are described for the first time. 
They may represent another facet of B. cereus 
pathogenicity through the secretion of metal-
loproteinase (camelysine) [9]. This is reflected 
by the invasion and dissection of blood vessel 
walls with superimposed occlusion of local 
blood vessels that might have contributed to 
ischemia and necrosis. In the necrotic areas, 
a rather small number of macrophages were 
seen, and this can be explained by macro-
phage apoptosis induced by hemolysin II [10].
In our case, the role of corticosteroid 
therapy is unknown and could explain the 
fatal outcome by enhancing immunode-
ficiency, with lack of lymphoid infiltrate 
both in the brain and in the liver. However, 
when compared to quite a similar case (No. 
19) of Tusgul’s series [4], also treated by a 
high dose of corticosteroid therapy but with 
favorable outcome, the only risk factor was 
the type of antibiotic treatment at the time 
of corticosteroid therapy. Thus, since B. ce-
reus was not isolated at that time, our patient 
was managed by cefepime empiric antibiotic 
treatment for which B. cereus is known to be 
resistant due to β-lactamase secretion [11]. 
This fact highlights the clinical challenge to 
diagnose B. cereus and the importance of the 
delay between the detection of B. cereus and 
the establishment of an effective, targeted 
antibiotic therapy in fragile patients.
Finally, nearly all of the criteria for a fatal 
outcome of B. cereus bacteremia were pres-
ent in this patient [3, 5, 12]: hematological 
disease/AML, reintroduction of chemothera-
py, severe neutropenia/aplasia, delayed treat-
ment due to delayed identification of bacilli, 
previous antibiotic treatment, corticosteroid 
therapy, and central venous catheter, which 
was probably the route of entry.
CNS symptomatology is another predic-
tor of unfavorable prognosis [3]. Our patient 
experienced an episode of fever and head-
ache during the previous cycle of chemo-
therapy, but this was probably not related 
to B. cereus infection since blood and urine 
cultures remained negative, and the patient 
recovered between the first and second cycle 
of chemotherapy.
This case confirms that even if B. cereus 
bacteremia is rare, in patients with acute leu-
kemia undergoing chemotherapy, pathoge-
nicity of B. cereus can be high. It represents 
a diagnostic challenge for clinicians and 
microbiologists alike. Neuropathological ex-
amination enables identification and better 
characterization of brain parenchyma altera-
tions resulting from toxins secreted by B. ce-
reus and, notably, the possible blood vessel 
lesions that are reported here for the first 
time. All of this underlines the importance of 
neuro-autopsy in an age of declining autopsy 
rates in most countries around the globe.
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